Rocket Pharmaceuticals Inc. RCKT
Super Investor & Insider
1
Fondi che lo detengono
#997
Rank consenso
1.4%
% dei portafogli
$12.8M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | 0.15% | Add 41.95% | 3,567,372 | $12.8M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Rocket Pharmaceuticals Inc. is a late-stage biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company employs a multi-platform approach utilizing both adeno-associated viral (AAV) and lentiviral vector (LV) technologies to address genetic disorders with signific…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees299
TickerRCKT
Statistics
Market Cap$345.4M
Revenue (TTM)$0
Net Income-$223.1M
Net Margin—
EPS$-2.01
P/E-1.37
P/S—
P/B1.22
EV/EBITDA-0.81
ROE-64.4%
Dividend Yield—
Price$3.17
Data: Twelve Data · Revenue = mcap / P/S